T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2014
|
| In: |
Lung cancer
Year: 2014, Jahrgang: 84, Heft: 3, Pages: 295-300 |
| ISSN: | 1872-8332 |
| DOI: | 10.1016/j.lungcan.2014.03.011 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.lungcan.2014.03.011
|
| Verfasserangaben: | Wei Li, Shengxiang Ren, Jiayu Li, Aiwu Li, Lihong Fan, Xuefei Li, Cao Zhao, Yayi He, Guanghui Gao, Xiaoxia Chen, Shuai Li, Jingyun Shi, Caicun Zhou, Ke Fei, Gerald Schmid-Bindert |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1524739537 | ||
| 003 | DE-627 | ||
| 005 | 20220812143540.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160127s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2014.03.011 |2 doi | |
| 035 | |a (DE-627)1524739537 | ||
| 035 | |a (DE-576)454739532 | ||
| 035 | |a (DE-599)BSZ454739532 | ||
| 035 | |a (OCoLC)1340897155 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Li, Wei |e VerfasserIn |0 (DE-627)1480475548 |0 (DE-576)410475548 |4 aut | |
| 245 | 1 | 0 | |a T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients |c Wei Li, Shengxiang Ren, Jiayu Li, Aiwu Li, Lihong Fan, Xuefei Li, Cao Zhao, Yayi He, Guanghui Gao, Xiaoxia Chen, Shuai Li, Jingyun Shi, Caicun Zhou, Ke Fei, Gerald Schmid-Bindert |
| 264 | 1 | |c June 2014 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 27.01.2016 | ||
| 700 | 1 | |a Schmid-Bindert, Gerald |d 1969- |e VerfasserIn |0 (DE-588)121300129 |0 (DE-627)081214170 |0 (DE-576)292636024 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lung cancer |d Amsterdam [u.a.] : Elsevier, 1985 |g 84(2014), 3, Seite 295-300 |h Online-Ressource |w (DE-627)320649733 |w (DE-600)2025812-4 |w (DE-576)264627539 |x 1872-8332 |7 nnas |a T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients |
| 773 | 1 | 8 | |g volume:84 |g year:2014 |g number:3 |g pages:295-300 |g extent:6 |a T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lungcan.2014.03.011 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20160127 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 121300129 |a Schmid-Bindert, Gerald |m 121300129:Schmid-Bindert, Gerald |d 60000 |d 61800 |e 60000PS121300129 |e 61800PS121300129 |k 0/60000/ |k 1/60000/61800/ |p 15 |y j | ||
| 999 | |a KXP-PPN1524739537 |e 2895900388 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am: 27.01.2016"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2025812-4"],"issn":["1872-8332"],"eki":["320649733"]},"part":{"year":"2014","pages":"295-300","text":"84(2014), 3, Seite 295-300","volume":"84","extent":"6","issue":"3"},"note":["Gesehen am 20.02.20"],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1985","dateIssuedDisp":"1985-","publisher":"Elsevier"}],"title":[{"title":"Lung cancer","title_sort":"Lung cancer","subtitle":"journal of the International Association for the Study of Lung Cancer"}],"pubHistory":["1.1985 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320649733","disp":"T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsLung cancer","language":["eng"]}],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1524739537"],"doi":["10.1016/j.lungcan.2014.03.011"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients","title_sort":"T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients"}],"language":["eng"],"person":[{"role":"aut","display":"Li, Wei","given":"Wei","family":"Li"},{"display":"Schmid-Bindert, Gerald","given":"Gerald","family":"Schmid-Bindert","role":"aut"}],"origin":[{"dateIssuedDisp":"June 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Wei Li, Shengxiang Ren, Jiayu Li, Aiwu Li, Lihong Fan, Xuefei Li, Cao Zhao, Yayi He, Guanghui Gao, Xiaoxia Chen, Shuai Li, Jingyun Shi, Caicun Zhou, Ke Fei, Gerald Schmid-Bindert"]},"recId":"1524739537"} | ||
| SRT | |a LIWEISCHMIT790MMUTAT2014 | ||